| Q38307906 | An integrated map of p53-binding sites and histone modification in the human ENCODE regions |
| Q28582825 | Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation |
| Q33475117 | Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73. |
| Q40290190 | Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. |
| Q24301527 | HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53 |
| Q34496093 | Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death |
| Q24529998 | ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation |
| Q37014644 | Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites |
| Q35900622 | Mechanisms of p53 activation and physiological relevance in the developing kidney. |
| Q24655422 | Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage |
| Q39601518 | Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells |
| Q25256835 | Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. |
| Q36710840 | Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. |
| Q38811135 | The Dual Nature of Nek9 in Adenovirus Replication |
| Q28473733 | The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound |
| Q24298372 | The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions |
| Q92062954 | The multiple mechanisms that regulate p53 activity and cell fate |
| Q24683529 | The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor |
| Q46891002 | The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model |
| Q39991040 | Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis |
| Q35665438 | Whole-genome cartography of p53 response elements ranked on transactivation potential. |
| Q53561930 | p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. |
| Q35646680 | p53 and p73 display common and distinct requirements for sequence specific binding to DNA |
| Q33376888 | p53 induces distinct epigenetic states at its direct target promoters |
| Q34578157 | p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. |